Biogen, Inc. (BIIB)
226.04
+6.97
(+3.18%)
USD |
NASDAQ |
Sep 22, 11:25
Biogen Price : 226.04 for Sept. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 21, 2026 | 216.14 | 221.92 | 214.59 | 219.07 | 928562.0 |
| Sep 18, 2026 | 219.05 | 220.17 | 215.26 | 215.50 | 2.636M |
| Sep 17, 2026 | 217.68 | 219.41 | 215.33 | 219.05 | 836707.0 |
| Sep 16, 2026 | 216.41 | 218.29 | 214.81 | 216.01 | 606493.0 |
| Sep 15, 2026 | 216.71 | 216.71 | 213.54 | 216.17 | 756047.0 |
| Sep 14, 2026 | 221.00 | 222.24 | 215.56 | 217.36 | 629931.0 |
| Sep 11, 2026 | 216.75 | 219.76 | 214.71 | 217.15 | 1.076M |
| Sep 10, 2026 | 209.92 | 216.70 | 208.93 | 215.43 | 936643.0 |
| Sep 09, 2026 | 210.50 | 213.48 | 209.00 | 210.73 | 694669.0 |
| Sep 08, 2026 | 215.45 | 217.28 | 210.54 | 212.50 | 617829.0 |
| Sep 04, 2026 | 221.15 | 223.82 | 219.82 | 220.83 | 465108.0 |
| Sep 03, 2026 | 225.44 | 225.80 | 221.23 | 224.51 | 550745.0 |
| Sep 02, 2026 | 218.20 | 225.59 | 216.97 | 222.67 | 1.268M |
| Sep 01, 2026 | 218.11 | 219.30 | 213.60 | 216.04 | 785497.0 |
| Aug 31, 2026 | 216.47 | 218.89 | 213.58 | 216.65 | 831004.0 |
| Aug 28, 2026 | 221.17 | 222.00 | 216.78 | 218.50 | 517485.0 |
| Aug 27, 2026 | 219.39 | 222.11 | 217.53 | 221.50 | 497524.0 |
| Aug 26, 2026 | 219.34 | 222.00 | 218.69 | 221.07 | 647334.0 |
| Aug 25, 2026 | 218.93 | 222.85 | 218.00 | 220.77 | 495435.0 |
| Aug 24, 2026 | 216.40 | 218.50 | 213.96 | 218.12 | 649828.0 |
| Aug 21, 2026 | 217.76 | 219.12 | 215.00 | 216.78 | 722348.0 |
| Aug 20, 2026 | 217.98 | 221.29 | 214.16 | 214.35 | 808625.0 |
| Aug 19, 2026 | 215.33 | 222.15 | 215.08 | 221.56 | 886914.0 |
| Aug 18, 2026 | 211.00 | 214.06 | 210.01 | 212.55 | 694009.0 |
| Aug 17, 2026 | 208.36 | 210.49 | 207.62 | 209.15 | 617238.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 45.66 |
| AbbVie, Inc. | 266.64 |
| Gilead Sciences, Inc. | 152.43 |
| Regeneron Pharmaceuticals, Inc. | 805.54 |
| Amgen, Inc. | 411.30 |
Price Related Metrics
| PE Ratio | 40.03 |
| PS Ratio | 3.456 |
| Price to Book Value | 1.771 |
| Price to Free Cash Flow | 13.41 |
| Earnings Yield | 2.50% |
| Market Cap | 33.39B |
| Operating PE Ratio | 17.73 |
| Normalized PE Ratio | 24.74 |